Investigation of differentially expressed genes in ER plus PR- invasive breast cancer

被引：0
|
作者：
Althobiti, M. M. A. [1 ]
Albugami, R. R. A. [2 ]
Alnamnakani, M. M. A. [2 ]
Alharbi, S. A. A. [1 ]
Lashin, A. G. [3 ]
机构：
[1] Shaqra Univ, Riyadh, Saudi Arabia
[2] King Fahad Med City, Riyadh, Saudi Arabia
[3] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2024年 / 264卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P18
引用
收藏
页码：S11 / S12
页数：2
相关论文
共 50 条
  • [41] Differentially expressed genes and their pathways in breast cancer patients with mesenchymal CTC
    Mego, Michal
    Hadzega, Dominik
    Minarik, Gabriel
    Soltysova, Andrea
    Nemcova, Petra
    Kalavska, Katarina
    Karaba, Marian
    Benca, Juraj
    Sedlackova, Tatiana
    Pindak, Daniel
    Klucar, Lubos
    CANCER RESEARCH, 2023, 83 (05)
  • [42] Genes differentially expressed in prostate cancer
    Pitts, WR
    BJU INTERNATIONAL, 2004, 94 (06) : 937 - 938
  • [43] Genes differentially expressed in prostate cancer
    Eder, IE
    Bektic, J
    Haag, P
    Bartsch, G
    Klocker, H
    BJU INTERNATIONAL, 2004, 93 (08) : 1151 - 1155
  • [44] GRP78 is neither expressed on ER-/PR-/Her2- human breast cancer cell surface nor secreted in the culture media
    Serrano, Jesus E.
    Romero-Nutz, Eva C.
    Sanchez, Neysharie
    Banerjee, Aditi
    Baksi, Krishna
    Banerjee, Dipak K.
    CANCER RESEARCH, 2017, 77
  • [45] Quantifying the relative value of drug therapy options in HER2+, ER-/PR- breast cancer
    Whang, John
    Steinkellner, Amy R.
    Borne, Jane M.
    Piana, Elizabeth N.
    Wong, Winston
    Aubert, Ronald E.
    Selby, Norman C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Clinicopathological differences and survival benefit in ER+/PR+/HER2+vs ER+/PR-/HER2+breast cancer subtypes
    Ding, Wu
    Ye, Dengfeng
    Chen, Haifeng
    Lin, Yingli
    Li, Zhian
    Tu, Chuanjian
    BREAST CANCER, 2024, 31 (02) : 295 - 304
  • [47] Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+MCF7 Breast Cancer Cells
    Lanceta, Lilibeth
    O'Neill, Conor
    Lypova, Nadiia
    Li, Xiahong
    Rouchka, Eric
    Waigel, Sabine
    Gomez-Gutierrez, Jorge G.
    Chesney, Jason
    Imbert-Fernandez, Yoannis
    GENES, 2020, 11 (04)
  • [48] Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-/PR- breast cancer cells
    Elena E. Tzekaki
    George Geromichalos
    Sophia N. Lavrentiadou
    Maria P. Tsantarliotou
    Anastasia A. Pantazaki
    Angelos Papaspyropoulos
    Breast Cancer Research and Treatment, 2021, 186 : 305 - 316
  • [49] Detection of differentially expressed genes in breast cancer with cDNA-array hybridization
    Ahr, A
    Holtrich, U
    Karn, T
    Solbach, C
    Gätje, R
    Scharl, A
    Strebhardt, K
    Kaufmann, M
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2000, 60 (08) : 412 - 417
  • [50] Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer
    Dahl, E
    Sadr-Nabavi, A
    Klopocki, E
    Betz, B
    Grube, S
    Kreutzfeld, R
    Himmelfarb, M
    An, HX
    Gelling, S
    Klaman, I
    Hinzmann, B
    Kristiansen, G
    Grützmann, R
    Kuner, R
    Petschke, B
    Rhiem, K
    Wiechen, K
    Sers, C
    Wiestler, O
    Schneider, A
    Höfler, H
    Nährig, J
    Dietel, M
    Schäfer, R
    Rosenthal, A
    Schmutzler, R
    Dürst, M
    Meindl, A
    Niederacher, D
    JOURNAL OF PATHOLOGY, 2005, 205 (01): : 21 - 28
12345